Initial findings from the Every Woman Study™: Low- and Middle-Income Countries is published in The Lancet Obstetrics, ...
A team of 30 doctors helped Suze Lopez, 41, deliver her son — and remove the tumor — in a "profound" medical marvel.
The addition of the immune checkpoint inhibitor Tecentriq (atezolizumab) to neoadjuvant chemotherapy and as a single agent ...
GLP-1 RAs probably have little or no effect on risk for thyroid cancer, pancreatic cancer, breast cancer, or kidney cancer.
IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable tolerability across ...
The latest announcement is out from Amplia Therapeutics ( (AU:ATX) ).
About 55 Penn Middle School students and staff packed and donated tote bags for local cancer patients in honor of late ...
A Bakersfield family received the shock of a lifetime after a woman learned she was pregnant with her baby growing inside of her abdomen.
At SABCS, Mayo Clinic researchers reported PRS data was more likely to change the risk categories of people with variants in moderate risk penetrance genes.
Menopause after breast cancer can cause symptoms that substantially impact quality of life, making individualized, multidisciplinary care and shared decision-making critical, experts noted during ...
Gynecological malignancies constitute a rather significant health burden, worldwide, with an incidence rate of approximately 30.4 per 100,000 population.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback